scientific article; zbMATH DE number 2062254
From MaRDI portal
Publication:4459136
zbMATH Open1052.92032MaRDI QIDQ4459136FDOQ4459136
Authors: Andrzej Świerniak, Urszula Ledzewicz, Heinz Schättler
Publication date: 25 March 2004
Full work available at URL: https://eudml.org/doc/207650
Title of this publication is not available (Why is that?)
Recommendations
- Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity
- Optimal control for a stochastic model of cancer chemotherapy
- scientific article; zbMATH DE number 3999722
- Optimal controls for a 3-compartment model for cancer chemotherapy with quadratic objective
- Optimal bang-bang controls for a two-compartment model in cancer chemotherapy
- An optimal control problem in cancer chemotherapy
- Application of optimal control theory to analysis of cancer chemotherapy regimens
- Optimal control of cancer chemotherapy model using the coupled Adomian/Alienor methods
- Ultimate dynamics and optimal control of a multi-compartment model of tumor resistance to chemotherapy
- Optimal control for a mathematical model for chemotherapy with pharmacometrics
Medical applications (general) (92C50) Optimality conditions for solutions belonging to restricted classes (Lipschitz controls, bang-bang controls, etc.) (49K30) Applications of optimal control and differential games (49N90)
Cited In (54)
- Optimal Control on a Model for Cervical Cancer
- Stabilization of a class of stochastic nonlinear systems using a bang‐bang controller
- Fields of extremals and sensitivity analysis for multi-input bilinear optimal control problems
- Competition between populations: preventing domination of resistant population using optimal control
- Optimal bounded controls problem for bilinear systems
- Mathematical modeling of the spread of COVID-19 among different age groups in Morocco: optimal control approach for intervention strategies
- Design of personalized cancer treatments by use of optimal control problems: the case of chronic myeloid leukemia
- ANALYSIS OF A CELL-CYCLE SPECIFIC MODEL FOR CANCER CHEMOTHERAPY
- Sufficient conditions for strong local optimality in optimal control problems with \(L_{2}\)-type objectives and control constraints
- A tumor-immune model with mixed immunotherapy and chemotherapy: qualitative analysis and optimal control
- Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics
- Optimal control homotopy perturbation method for cancer model
- Dynamics and control of a mathematical model for metronomic chemotherapy
- Optimal Control Applied to Cell-Cycle-Specific Cancer Chemotherapy
- On optimal delivery of combination therapy for tumors
- Combination of antiangiogenic treatment with chemotherapy as a multi‐input optimal control problem
- Optimal syntheses for state constrained problems with application to optimization of cancer therapies
- Optimal controls for a 3-compartment model for cancer chemotherapy with quadratic objective
- Segmentation of breast cancer fine needle biopsy cytological images
- Title not available (Why is that?)
- Optimal control of the Lotka-Volterra system: turnpike property and numerical simulations
- Constrained bilinear control problem: application to a cancer chemotherapy model
- On the role of the objective in the optimization of compartmental models for biomedical therapies
- Title not available (Why is that?)
- Optimal control of compartmental models: the exact solution
- Determination of the optimal therapeutic protocols in cancer immunotherapy
- Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes
- Optimal control for a mathematical model for chemotherapy with pharmacometrics
- On the analysis of a mathematical model of CAR-T cell therapy for glioblastoma: insights from a mathematical model
- Optimal bang-bang controls for a two-compartment model in cancer chemotherapy
- Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity
- Cancer immunotherapy, mathematical modeling and optimal control
- Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemo\-therapy
- Regulation of p53 by SIRNA in radiation treated cells: simulation studies
- Multiscale cancer modeling: In the line of fast simulation and chemotherapy
- Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors
- Optimal control problem in an epidemic disease SIS model with stages and delays
- Tumor development under combination treatments with anti-angiogenic therapies
- On the role of tumor heterogeneity for optimal cancer chemotherapy
- Optimal control of cancer chemotherapy with delays and state constraints
- Comparison of optimal controls for a model in cancer chemotherapy withL1- andL2-type objectives
- Optimal control analysis of a leukemia model under Imatinib treatment
- Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls
- Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model
- Sufficient conditions and sensitivity analysis for optimal bang-bang control problems with state constraints
- Optimal control of cancer treatments: mathematical models for the tumor microenvironment
- Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach
- A discrete mathematical modeling and optimal control of the electoral behavior with regard to a political party
- Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy
- Optimization of an amplification protocol for misfolded proteins by using relaxed control
- Optimal control problems for differential equations applied to tumor growth: state of the art
- On applications of the Hamilton-Jacobi equations and optimal control theory to problems of chemotherapy of malignant tumors
- Immune therapeutic strategies using optimal controls with \(L^{1}\) and \(L^{2}\) type objectives
- Optimization of additive chemotherapy combinations for an in vitro cell cycle model with constant drug exposures
This page was built for publication:
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4459136)